Business Of Biotech Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.
Dec 2, 2024
Woody Bryan, Ph.D., President and CEO of Revolo Biotherapeutics, dives into the innovative realm of peptide therapeutic delivery. He shares his transition to CEO and the bold strategic decision to shift the administration method for peptide candidates targeting allergies and autoimmune diseases. The discussion highlights the evolution of drug delivery methods, focusing on subcutaneous administration and the patient-centric approach. Bryan also outlines the importance of collaboration, early research data, and the upcoming clinical trials set to redefine their therapeutic landscape.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 2min
Navigating Leadership Transitions in Biopharma
01:34 • 3min
Innovations in Peptide Drug Delivery
04:25 • 16min
Navigating the Shift to Subcutaneous Drug Delivery
20:18 • 3min
From Scientist to Business Leader
23:00 • 16min
Upcoming Clinical Trials and Timelines for Peptide Delivery Research
39:09 • 1min
Team Dynamics in Next-Gen Therapies
40:38 • 5min